Works matching IS 13520504 AND DT 2017 AND VI 24 AND IP 1

Results: 15

Factors associated with poor adherence to antiviral treatment for hepatitis B.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 53, doi. 10.1111/jvh.12582

By:

Allard, N.;
Dev, A.;
Dwyer, J.;
Srivatsa, G.;
Thompson, A.;
Cowie, B.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 1, doi. 10.1111/jvh.12585
Publication type:: Article

Cover Image.

Published in:: Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. i, doi. 10.1111/jvh.12586
Publication type:: Article

Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 17, doi. 10.1111/jvh.12609

By:

Wong, R. J.;
Nguyen, M. T.;
Trinh, H. N.;
Huynh, A.;
Ly, M. T.;
Nguyen, H. A.;
Nguyen, K. K.;
Yang, J.;
Garcia, R. T.;
Levitt, B.;
Silveira, E.;
Gish, R. G.

Publication type:

Article

Hepatitis C in nonobese nondiabetic patients: Insulin resistance and the metabolic syndrome make a difference.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 86, doi. 10.1111/jvh.12610

By:

Crisan, D.;
Radu, C.;
Suciu, A.;
Leach, N.;
Stefanescu, H.;
Avram, L.;
Crisan, N.;
Grigorescu, M.

Publication type:

Article

Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 22, doi. 10.1111/jvh.12611

By:

Tapper, E. B.;
Bacon, B. R.;
Curry, M. P.;
Dieterich, D. T.;
Flamm, S. L.;
Guest, L. E.;
Kowdley, K. V.;
Lee, Y.;
Tsai, N. C.;
Younossi, Z. M.;
Afdhal, N. H.

Publication type:

Article

Patients with HBV-related acute-on-chronic liver failure have increased concentrations of extracellular histones aggravating cellular damage and systemic inflammation.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 59, doi. 10.1111/jvh.12612

By:

Li, X.;
Gou, C.;
Yao, L.;
Lei, Z.;
Gu, T.;
Ren, F.;
Wen, T.

Publication type:

Article

No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg− patients with chronic hepatitis B after 8 years of treatment.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 68, doi. 10.1111/jvh.12613

By:

Liu, Y.;
Corsa, A. C.;
Buti, M.;
Cathcart, A. L.;
Flaherty, J. F.;
Miller, M. D.;
Kitrinos, K. M.;
Marcellin, P.;
Gane, E. J.

Publication type:

Article

Virology analyses of HCV genotype 4 isolates from patients treated with simeprevir and peginterferon/ribavirin in the Phase III RESTORE study.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 28, doi. 10.1111/jvh.12614

By:

Fevery, B.;
Verbinnen, T.;
Peeters, M.;
Janssen, K.;
Witek, J.;
Jessner, W.;
De Meyer, S.;
Lenz, O.

Publication type:

Article

Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 37, doi. 10.1111/jvh.12615

By:

Eltahla, A. A.;
Rodrigo, C.;
Betz‐Stablein, B.;
Grebely, J.;
Applegate, T.;
Luciani, F.;
Schinkel, J.;
Dore, G. J.;
Page, K.;
Bruneau, J.;
Morris, M. D.;
Cox, A. L.;
Kim, A. Y.;
Shoukry, N. H.;
Lauer, G. M.;
Maher, L.;
Hellard, M.;
Prins, M.;
Lloyd, A. R.;
Bull, R. A.

Publication type:

Article

Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC<sup>3</sup> Study.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 43, doi. 10.1111/jvh.12616

By:

Rodrigo, C.;
Eltahla, A. A.;
Bull, R. A.;
Luciani, F.;
Grebely, J.;
Dore, G. J.;
Applegate, T.;
Page, K.;
Bruneau, J.;
Morris, M. D.;
Cox, A. L.;
Osburn, W.;
Kim, A. Y.;
Shoukry, N. H.;
Lauer, G. M.;
Maher, L.;
Schinkel, J.;
Prins, M.;
Hellard, M.;
Lloyd, A. R.

Publication type:

Article

Hepatitis C virus genotype 4: Genotype 1's little brother.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 4, doi. 10.1111/jvh.12620

By:

Llaneras, J.;
Riveiro‐Barciela, M.;
Buti, M.;
Esteban, R.

Publication type:

Article

Time course of hepatitis E-specific antibodies in adults.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 75, doi. 10.1111/jvh.12621

By:

Schemmerer, M.;
Rauh, C.;
Jilg, W.;
Wenzel, J. J.

Publication type:

Article

Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse<sup>®</sup> G600 analyzer.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 80, doi. 10.1111/jvh.12622

By:

Sultanik, P.;
Ginguay, A.;
Vandame, J.;
Popovici, T.;
Meritet, J.‐F.;
Cynober, L.;
Pol, S.;
Bories, P.‐N.

Publication type:

Article

Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort.

Published in:

Journal of Viral Hepatitis, 2017, v. 24, n. 1, p. 13, doi. 10.1111/jvh.12651

By:

Vukotic, R.;
Di Donato, R.;
Conti, F.;
Scuteri, A.;
Serra, C.;
Andreone, P.

Publication type:

Article